Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AP 5346

X
Drug Profile

AP 5346

Alternative Names: AP5346; ASK-H03; Polymer-DACH platinum conjugate - PlasmaTech Biopharmaceuticals; ProLindac

Latest Information Update: 05 Aug 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of London School of Pharmacy
  • Developer PlasmaTech Biopharmaceuticals
  • Class Antineoplastics; Platinum complexes
  • Mechanism of Action Alkylating agents; DNA cross linking agents; DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cholangiocarcinoma; Colorectal cancer; Head and neck cancer; Ovarian cancer

Most Recent Events

  • 31 Dec 2011 Phase-II clinical trials in Cholangiocarcinoma in Europe (IV)
  • 01 Nov 2010 Phase-II clinical trials in Ovarian cancer (Combination therapy, Second-line therapy or greater, Late-stage disease, Metastatic disease) in France (IV) (EudraCT2010-020030-25)
  • 21 Apr 2009 Pharmacokinetics data from a Preclinical trial presented at the 100th Annual Meeting of the American Association for Cancer Research (AACR-2009)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top